Developer docs
API playgroundTry for free, no card

Search company profiles

Orthofix

Full company profile

uuid0002ve2

Namestring
Orthofix
Legal namestring
Orthofix Medical Inc.
Company typeenum
Public
Founded yearint
1980
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersLewisville, United States
HQ citystring
Lewisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spine medical devices, bone growth stimulation, surgical navigation systems, limb reconstruction devices, orthopedic biologics
Industry4 codes
1Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryYes
2Spine (Orthopedic Spine)
CodeHLAKALAEPrimaryNo
3Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports)
CodeHLAHAMACPrimaryNo
4Orthopedic Surgery (Operative Orthopedics)
CodeHLAKALACPrimaryNo
NAICS code5 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Orthopedic Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Spine Solutions
TypeHardware Sales
Description

Complete spine portfolio including implants, fixation systems, interbody devices, and biologics for spinal reconstruction and fusion procedures. Includes anterior/posterior cervical fixation, thoracolumbar fixation, SI fusion, and vertebral body replacement.

biospace.com
2Limb Reconstruction
TypeHardware Sales
Description

Industry-leading portfolio addressing congenital, developmental, and acquired orthopedic conditions including limb preservation, deformity correction, limb lengthening, and complex fracture management.

biospace.com
3Bone Growth Therapies (Therapeutic Solutions)
TypeHardware Sales
Description

Non-invasive bone growth stimulation devices (SpinalStim, CervicalStim, PhysioStim, AccelStim) and bracing solutions. Represents approximately 25-30% of company sales. Bone growth therapies showed 7% growth in Q4 2025.

biospace.com
4Biologics
TypeHardware Sales
Description

Comprehensive biologics portfolio including allografts (Trinity Elite, FiberFuse), synthetic grafts (OsteoCove), demineralized bone matrix, and bone graft substitutes processed by MTF Biologics.

orthofix.com
5Surgical Navigation
TypeHardware Sales
Description

7D FLASH Navigation System and FLASH EVD Cranial Navigation Platform enabling image-guided surgical procedures with machine-vision technology.

orthofix.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Medical devices and implants sold via quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed - B2B medical device sales through healthcare providers, hospitals, and surgical centers with contractual pricing arrangements.

orthofix.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1SeaSpine
Description

Limb Reconstruction Corporation subsidiary providing limb reconstruction solutions

orthofix.com
+8 more records
Core offering1 text field

Orthofix designs, manufactures, and sells medical devices and biologic solutions for spine surgery, limb reconstruction, and orthopedic trauma. Its core offerings include spinal implants and fixation systems, biologics (allografts and synthetic grafts), FDA-cleared PEMF bone growth stimulation devices, and the 7D FLASH machine-vision surgical navigation system. These products are sold to surgeons, hospitals, and ambulatory surgery centers for use in spinal fusion, deformity correction, limb lengthening, fracture management, and non-invasive bone healing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 84% clinical success rate for CervicalStim bone growth stimulation
+5 more records
Product overview1 text field

Orthofix is a global medical technology company offering a comprehensive portfolio of spine, biologics, therapeutic solutions, and limb reconstruction products. The portfolio includes surgical navigation systems (7D FLASH Navigation), bone growth stimulation devices (SpinalStim, CervicalStim, PhysioStim, AccelStim), spinal implants and fixation systems (Virata, Firebird, Reef L, WaveForm), biologics (Trinity Elite, FiberFuse, Opus), and limb reconstruction solutions (FITBONE, TrueLok, OrthoNext). The product architecture combines hardware-based medical devices with enabling software platforms (STIM onTrack mobile app, OrthoNext planning software, 7D FLASH Navigation). The portfolio is organized across four main business segments: Spine Solutions (implant systems, biologics, navigation), Biologics (allografts, synthetic grafts, bone matrices), Therapeutic Solutions (bone growth stimulators, bracing, patient support apps), and Limb Reconstruction (lengthening, deformity correction, fracture management).

Product and service27 records
17D FLASH Navigation System
CategorySurgical Navigation Systems
Description

Machine-vision surgical navigation system that captures and reconstructs 3D images for radiation-free or reduced-radiation spine and cranial procedures, with patient registration reduced from 30 minutes to 30 seconds. Sold to hospitals and ambulatory surgery centers.

2SpinalStim
CategoryBone Growth Stimulation Devices
Description

Pulsed electromagnetic field (PEMF) bone growth stimulation device used as a non-invasive adjunctive therapy for lumbar and thoracic spinal fusion, prescribed by orthopedic and spine surgeons for high-risk fusion patients.

3CervicalStim
CategoryBone Growth Stimulation Devices
Description

FDA-approved PEMF bone growth stimulation device specifically for cervical spine fusion, the only device approved for non-invasive adjunctive cervical fusion treatment in high-risk patients. Demonstrates 84% clinical success rate and a 22% increase in fusion success when used adjunctively.

4PhysioStim
CategoryBone Growth Stimulation Devices
Description

Non-invasive PEMF bone growth stimulation device for fracture healing and bone regeneration therapy, prescribed for non-union fractures and bone healing applications.

5AccelStim
CategoryBone Growth Stimulation Devices
Description

Advanced bone healing therapy device using PEMF technology with new features while maintaining the proven clinical results of earlier generations.

6Trinity Elite
CategoryOrthopedic Biologics
Description

Allograft with viable cells containing osteoconductive scaffold, osteoinductive potential, and osteogenic cells including mesenchymal stem cells for bone formation support in spinal and orthopedic procedures. Over 350,000 patients implanted over 15+ years.

7FiberFuse Advanced
CategoryOrthopedic Biologics
Description

100% bone allograft consisting of demineralized cortical fibers and mineralized cancellous bone granules for bone healing in a moldable format, processed by MTF Biologics.

8Opus Osteoconductive Scaffold
CategoryOrthopedic Biologics
Description

Osteoconductive scaffold product available in putty and strip formats for bone healing applications in spine and orthopedic procedures.

9M6-C Artificial Cervical Disc
CategorySpinal Implants
Description

Artificial cervical disc replacement device for motion-preserving treatment of cervical disc degeneration.

10Virata Spinal Fixation System
CategorySpinal Implants
Description

Posterior thoracolumbar fixation system for spinal fusion procedures, with full market release planned for H2 2026.

11Reef L Interbody System
CategorySpinal Implants
Description

Lateral lumbar interbody fusion cage system for minimally invasive lateral approach procedures.

12WaveForm L Interbody System
CategorySpinal Implants
Description

Lateral lumbar interbody fusion system incorporating WaveForm technology for enhanced visualization and surgical outcomes.

13Firebird SI Fusion System
CategorySpinal Implants
Description

Sacroiliac joint fusion system for treatment of SI joint dysfunction and low back pain.

14FITBONE Trochanteric Intramedullary Lengthening System
CategoryLimb Reconstruction Devices
Description

Pediatric limb lengthening system with trochanteric entry design featuring the smallest proximal diameter of any intramedullary lengthening device, for patients aged 12-21. Over 5,000 devices implanted worldwide.

15TrueLok Hexapod System
CategoryLimb Reconstruction Devices
Description

Ring fixation system for limb reconstruction using hexapod technology for precise deformity correction and limb lengthening, paired with the OrthoNext planning software.

16TrueLok EVO Ring Fixation System
CategoryLimb Reconstruction Devices
Description

Advanced ring fixation system for limb preservation recognized by the Italian Ministry of Enterprises and Made in Italy for medical device innovation.

17Galaxy Fixation System
CategoryLimb Reconstruction Devices
Description

External fixation system for orthopedic trauma procedures including the Gemini system with expanded sterile kit offerings for complex fracture management.

18Cetra Anterior Cervical Plate System
CategorySpinal Implants
Description

Anterior cervical plate system with low profile design, large graft windows, and up to 20 degrees screw angulation for anterior cervical fusion procedures.

19Hallmark Anterior Cervical Plating System
CategorySpinal Implants
Description

Anterior cervical plate system with narrow width for minimal tissue retraction, color-coded screws, and intuitive locking mechanism for anterior cervical fusion procedures.

20Construx Mini PEEK Spacer System
CategorySpinal Implants
Description

PEEK interbody spacer system for cervical interbody fusion with imaging-friendly properties.

21Construx Mini PTC Spacer System
CategorySpinal Implants
Description

PEEK/titanium hybrid cervical interbody spacer combining porous titanium endplates (400 micron pores, 50% porosity) for bone ingrowth with PEEK core for imaging compatibility.

22Construx Mini Ti Spacer System
CategorySpinal Implants
Description

3D-printed titanium cervical interbody with functional gradient porous structure for enhanced bone ingrowth potential in anterior cervical fusion procedures.

23Lonestar Cervical Stand Alone System
CategorySpinal Implants
Description

Cervical stand-alone interbody device combining implant and integrated plating for simplified single-level anterior cervical fusion procedures.

24OsteoCove Bioactive Synthetic Graft
CategoryOrthopedic Biologics
Description

Advanced bioactive synthetic bone graft for use in spine and orthopedic procedures, FDA 510(k) cleared.

25Rodeo Telescopic Nail
CategoryLimb Reconstruction Devices
Description

Telescopic intramedullary nail for orthopedic limb reconstruction procedures, FDA 510(k) cleared in 2025.

26WaveForm A 3D Printed Anterior Lumbar Interbody
CategorySpinal Implants
Description

3D-printed anterior lumbar interbody device incorporating WaveForm topography for optimized implant-bone interface in anterior lumbar fusion.

27Fitbone Transport and Lengthening System
CategoryLimb Reconstruction Devices
Description

FDA 510(k)-cleared motorized intramedullary system for combined bone transport and lengthening in complex limb reconstruction.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-14
Description

Strategic distribution partnership for KEOPS-4ME platform in the United States, enabling rollout of patient-specific K-Rods starting Q2 2026. SMAIO is a French-American spinal surgery technology company.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-14
Description

Strategic distribution partnership with Highridge Medical for spinal surgery technology distribution alongside Orthofix.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-20
Description

Distribution partnership with SMAIO for KEOPS-4ME platform, expanding Orthofix's offering in patient-specific spinal solutions.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Strategic partnership agreement for biologics and tissue regeneration products.

Strategic tierCoreTypeTechnology or Integration
Description

Exclusive processing partnership for allograft biologics including Trinity Elite, FiberFuse, and other bone graft substitutes. MTF has 30+ years of experience processing safe and efficacious allografts.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spine-focused medical device company that merged with NuVasive in 2023, creating the largest pure-play spine company globally. Directly competes with Orthofix across spinal implants, interbody devices, SI fusion, and biologics, and overlaps on surgical navigation and enabling technologies.

TypeBroad incumbent
Description

Large diversified medical technology company with material spine (acquired Wright Medical/K2M) and orthopedic trauma/extremities franchises. Competes directly with Orthofix in limb reconstruction, external fixation, and spine, with deeper resources and broader hospital relationships.

TypeBroad incumbent
Description

Global medical device leader with one of the largest spine businesses, including spinal implants, biologics, and enabling technologies. Overlaps with Orthofix in cervical and thoracolumbar fixation, interbody devices, and bone grafting solutions across a much larger installed base.

TypeBroad incumbent
Description

Major orthopedic medical device company with broad musculoskeletal portfolio including trauma, extremities, and spine (acquired Biomet). Competes with Orthofix in orthopedic trauma/extremity fixation and bone healing adjacencies through its comprehensive hospital footprint.

TypeBroad incumbent
Description

Spine and orthopedics franchise within J&J MedTech offering spinal implants, biologics, and trauma/extremity products. Overlaps with Orthofix across cervical/thoracolumbar fixation, interbody, and limb reconstruction, backed by significantly larger R&D and commercial scale.

TypeBroad incumbent
Description

Diversified medical device company with orthopedic reconstruction, trauma, and sports medicine franchises. Competes with Orthofix in orthopedic extremities and external fixation, with broader reach across global hospital systems.

TypeDirect peer
Description

Pure-play spine medical device company focused on procedurally integrated solutions for spine surgeons. Directly competes with Orthofix in lateral lumbar interbody, posterior fixation, and cervical procedures with a comparable mid-cap commercial profile.

TypeEmerging player
Description

Medical device company exclusively focused on sacroiliac joint fusion, directly competing with Orthofix's Firebird SI Fusion System. Specialized emerging player with category leadership but narrower portfolio than Orthofix.

TypeDirect peer
Description

Medical technology company with meaningful spine and orthopedic trauma/extremity fixation exposure. Competes with Orthofix in specialty orthopedic devices, including regenerative technologies and biologics used in spine and limb reconstruction.

TypeEmerging player
Description

Medical device company specializing in foot and ankle procedures, including bunion correction systems. Comparable to Orthofix's Limb Reconstruction segment in addressing complex musculoskeletal deformities, though in a more focused anatomical niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Orthofix

Orthopedic Medical Devicesorthofix.com

Orthofix firmographics

Firmographics
Name
Orthofix
Legal name
Orthofix Medical Inc.
Website
http://www.orthofix.com
Company type
Public
Founded year
1980
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Orthofix industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
akta.pro secondary industries
Spine (Orthopedic Spine) (HLAKALAE), Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), Orthopedic Surgery (Operative Orthopedics) (HLAKALAC)

Keywords

  • Spine medical devices
  • Bone growth stimulation
  • Surgical navigation systems
  • Limb reconstruction devices
  • Orthopedic biologics

Where Orthofix is headquartered

Location

Headquarters

HQ city
Lewisville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Orthofix business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Spine Solutions: Complete spine portfolio including implants, fixation systems, interbody devices, and biologics for spinal reconstruction and fusion procedures. Includes anterior/posterior cervical fixation, thoracolumbar fixation, SI fusion, and vertebral body replacement.
  2. Limb Reconstruction: Industry-leading portfolio addressing congenital, developmental, and acquired orthopedic conditions including limb preservation, deformity correction, limb lengthening, and complex fracture management.
  3. Bone Growth Therapies (Therapeutic Solutions): Non-invasive bone growth stimulation devices (SpinalStim, CervicalStim, PhysioStim, AccelStim) and bracing solutions. Represents approximately 25-30% of company sales. Bone growth therapies showed 7% growth in Q4 2025.
  4. Biologics: Comprehensive biologics portfolio including allografts (Trinity Elite, FiberFuse), synthetic grafts (OsteoCove), demineralized bone matrix, and bone graft substitutes processed by MTF Biologics.
  5. Surgical Navigation: 7D FLASH Navigation System and FLASH EVD Cranial Navigation Platform enabling image-guided surgical procedures with machine-vision technology.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractMedical devices and implants sold via quote-based pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Orthofix product offering

Product offering

Core offering

Orthofix designs, manufactures, and sells medical devices and biologic solutions for spine surgery, limb reconstruction, and orthopedic trauma. Its core offerings include spinal implants and fixation systems, biologics (allografts and synthetic grafts), FDA-cleared PEMF bone growth stimulation devices, and the 7D FLASH machine-vision surgical navigation system. These products are sold to surgeons, hospitals, and ambulatory surgery centers for use in spinal fusion, deformity correction, limb lengthening, fracture management, and non-invasive bone healing.

Product overview

Orthofix is a global medical technology company offering a comprehensive portfolio of spine, biologics, therapeutic solutions, and limb reconstruction products. The portfolio includes surgical navigation systems (7D FLASH Navigation), bone growth stimulation devices (SpinalStim, CervicalStim, PhysioStim, AccelStim), spinal implants and fixation systems (Virata, Firebird, Reef L, WaveForm), biologics (Trinity Elite, FiberFuse, Opus), and limb reconstruction solutions (FITBONE, TrueLok, OrthoNext). The product architecture combines hardware-based medical devices with enabling software platforms (STIM onTrack mobile app, OrthoNext planning software, 7D FLASH Navigation). The portfolio is organized across four main business segments: Spine Solutions (implant systems, biologics, navigation), Biologics (allografts, synthetic grafts, bone matrices), Therapeutic Solutions (bone growth stimulators, bracing, patient support apps), and Limb Reconstruction (lengthening, deformity correction, fracture management).

Differentiator

Problem solved

Functional benefit

Brands

  • SeaSpine: Limb Reconstruction Corporation subsidiary providing limb reconstruction solutions
  • 7D FLASH Navigation
  • STIM onTrack
  • AccelStim
  • CervicalStim
  • SpinalStim
  • PhysioStim
  • Fitbone
  • TrueLok

Products and services

  • 7D FLASH Navigation System Machine-vision surgical navigation system that captures and reconstructs 3D images for radiation-free or reduced-radiation spine and cranial procedures, with patient registration reduced from 30 minutes to 30 seconds. Sold to hospitals and ambulatory surgery centers.
  • SpinalStim Pulsed electromagnetic field (PEMF) bone growth stimulation device used as a non-invasive adjunctive therapy for lumbar and thoracic spinal fusion, prescribed by orthopedic and spine surgeons for high-risk fusion patients.
  • CervicalStim FDA-approved PEMF bone growth stimulation device specifically for cervical spine fusion, the only device approved for non-invasive adjunctive cervical fusion treatment in high-risk patients. Demonstrates 84% clinical success rate and a 22% increase in fusion success when used adjunctively.
  • PhysioStim Non-invasive PEMF bone growth stimulation device for fracture healing and bone regeneration therapy, prescribed for non-union fractures and bone healing applications.
  • AccelStim Advanced bone healing therapy device using PEMF technology with new features while maintaining the proven clinical results of earlier generations.
  • Trinity Elite Allograft with viable cells containing osteoconductive scaffold, osteoinductive potential, and osteogenic cells including mesenchymal stem cells for bone formation support in spinal and orthopedic procedures. Over 350,000 patients implanted over 15+ years.
  • FiberFuse Advanced 100% bone allograft consisting of demineralized cortical fibers and mineralized cancellous bone granules for bone healing in a moldable format, processed by MTF Biologics.
  • Opus Osteoconductive Scaffold Osteoconductive scaffold product available in putty and strip formats for bone healing applications in spine and orthopedic procedures.
  • M6-C Artificial Cervical Disc Artificial cervical disc replacement device for motion-preserving treatment of cervical disc degeneration.
  • Virata Spinal Fixation System Posterior thoracolumbar fixation system for spinal fusion procedures, with full market release planned for H2 2026.
  • Reef L Interbody System Lateral lumbar interbody fusion cage system for minimally invasive lateral approach procedures.
  • WaveForm L Interbody System Lateral lumbar interbody fusion system incorporating WaveForm technology for enhanced visualization and surgical outcomes.
  • Firebird SI Fusion System Sacroiliac joint fusion system for treatment of SI joint dysfunction and low back pain.
  • FITBONE Trochanteric Intramedullary Lengthening System Pediatric limb lengthening system with trochanteric entry design featuring the smallest proximal diameter of any intramedullary lengthening device, for patients aged 12-21. Over 5,000 devices implanted worldwide.
  • TrueLok Hexapod System Ring fixation system for limb reconstruction using hexapod technology for precise deformity correction and limb lengthening, paired with the OrthoNext planning software.
  • TrueLok EVO Ring Fixation System Advanced ring fixation system for limb preservation recognized by the Italian Ministry of Enterprises and Made in Italy for medical device innovation.
  • Galaxy Fixation System External fixation system for orthopedic trauma procedures including the Gemini system with expanded sterile kit offerings for complex fracture management.
  • Cetra Anterior Cervical Plate System Anterior cervical plate system with low profile design, large graft windows, and up to 20 degrees screw angulation for anterior cervical fusion procedures.
  • Hallmark Anterior Cervical Plating System Anterior cervical plate system with narrow width for minimal tissue retraction, color-coded screws, and intuitive locking mechanism for anterior cervical fusion procedures.
  • Construx Mini PEEK Spacer System PEEK interbody spacer system for cervical interbody fusion with imaging-friendly properties.
  • Construx Mini PTC Spacer System PEEK/titanium hybrid cervical interbody spacer combining porous titanium endplates (400 micron pores, 50% porosity) for bone ingrowth with PEEK core for imaging compatibility.
  • Construx Mini Ti Spacer System 3D-printed titanium cervical interbody with functional gradient porous structure for enhanced bone ingrowth potential in anterior cervical fusion procedures.
  • Lonestar Cervical Stand Alone System Cervical stand-alone interbody device combining implant and integrated plating for simplified single-level anterior cervical fusion procedures.
  • OsteoCove Bioactive Synthetic Graft Advanced bioactive synthetic bone graft for use in spine and orthopedic procedures, FDA 510(k) cleared.
  • Rodeo Telescopic Nail Telescopic intramedullary nail for orthopedic limb reconstruction procedures, FDA 510(k) cleared in 2025.
  • WaveForm A 3D Printed Anterior Lumbar Interbody 3D-printed anterior lumbar interbody device incorporating WaveForm topography for optimized implant-bone interface in anterior lumbar fusion.
  • Fitbone Transport and Lengthening System FDA 510(k)-cleared motorized intramedullary system for combined bone transport and lengthening in complex limb reconstruction.

Quantifiable outcome

  • 84% clinical success rate for CervicalStim bone growth stimulation
  • +5 more outcomes

Companies that use Orthofix

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Orthofix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Orthofix partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and strategic.

  • SMAIOcoreChannel Partner/ Reseller/ Distributor · 14 April 2026Strategic distribution partnership for KEOPS-4ME platform in the United States, enabling rollout of patient-specific K-Rods starting Q2 2026. SMAIO is a French-American spinal surgery technology company.
  • Highridge MedicalcoreChannel Partner/ Reseller/ Distributor · 14 April 2026Strategic distribution partnership with Highridge Medical for spinal surgery technology distribution alongside Orthofix.
  • SMAIOcoreChannel Partner/ Reseller/ Distributor · 20 January 2026Distribution partnership with SMAIO for KEOPS-4ME platform, expanding Orthofix's offering in patient-specific spinal solutions.
  • CGBiostrategicStrategic or Co-development PartnerStrategic partnership agreement for biologics and tissue regeneration products.
  • MTF BiologicscoreTechnology or IntegrationExclusive processing partnership for allograft biologics including Trinity Elite, FiberFuse, and other bone graft substitutes. MTF has 30+ years of experience processing safe and efficacious allografts.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Orthofix competitors and assessment

Company assessment

Direct peers

  • Globus Medical: Spine-focused medical device company that merged with NuVasive in 2023, creating the largest pure-play spine company globally. Directly competes with Orthofix across spinal implants, interbody devices, SI fusion, and biologics, and overlaps on surgical navigation and enabling technologies.
  • Alphatec Holdings: Pure-play spine medical device company focused on procedurally integrated solutions for spine surgeons. Directly competes with Orthofix in lateral lumbar interbody, posterior fixation, and cervical procedures with a comparable mid-cap commercial profile.
  • Integra LifeSciences: Medical technology company with meaningful spine and orthopedic trauma/extremity fixation exposure. Competes with Orthofix in specialty orthopedic devices, including regenerative technologies and biologics used in spine and limb reconstruction.

Broad incumbents

  • Stryker Corporation: Large diversified medical technology company with material spine (acquired Wright Medical/K2M) and orthopedic trauma/extremities franchises. Competes directly with Orthofix in limb reconstruction, external fixation, and spine, with deeper resources and broader hospital relationships.
  • Medtronic: Global medical device leader with one of the largest spine businesses, including spinal implants, biologics, and enabling technologies. Overlaps with Orthofix in cervical and thoracolumbar fixation, interbody devices, and bone grafting solutions across a much larger installed base.
  • Zimmer Biomet: Major orthopedic medical device company with broad musculoskeletal portfolio including trauma, extremities, and spine (acquired Biomet). Competes with Orthofix in orthopedic trauma/extremity fixation and bone healing adjacencies through its comprehensive hospital footprint.
  • Johnson & Johnson (DePuy Synthes): Spine and orthopedics franchise within J&J MedTech offering spinal implants, biologics, and trauma/extremity products. Overlaps with Orthofix across cervical/thoracolumbar fixation, interbody, and limb reconstruction, backed by significantly larger R&D and commercial scale.
  • Smith+Nephew: Diversified medical device company with orthopedic reconstruction, trauma, and sports medicine franchises. Competes with Orthofix in orthopedic extremities and external fixation, with broader reach across global hospital systems.

Emerging players

  • SI-BONE: Medical device company exclusively focused on sacroiliac joint fusion, directly competing with Orthofix's Firebird SI Fusion System. Specialized emerging player with category leadership but narrower portfolio than Orthofix.
  • Treace Medical Concepts: Medical device company specializing in foot and ankle procedures, including bunion correction systems. Comparable to Orthofix's Limb Reconstruction segment in addressing complex musculoskeletal deformities, though in a more focused anatomical niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Orthofix social profiles

Digital presence

Orthofix compliance and trust

Trust signal

Compliance8 records

Orthofix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Orthofix leadership team

Management profile

Number of profiles

Profiles10 records

Orthofix subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Orthofix funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Orthofix M&A and investment

M&A and investment

M&A2 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orthofix

What does Orthofix do?

Orthofix designs, manufactures, and sells medical devices and biologic solutions for spine surgery, limb reconstruction, and orthopedic trauma. Its core offerings include spinal implants and fixation systems, biologics (allografts and synthetic grafts), FDA-cleared PEMF bone growth stimulation devices, and the 7D FLASH machine-vision surgical navigation system. These products are sold to surgeons, hospitals, and ambulatory surgery centers for use in spinal fusion, deformity correction, limb lengthening, fracture management, and non-invasive bone healing.

Is Orthofix a public or private company?

Orthofix is a public company. It is classified as public and is currently operating.

When was Orthofix founded?

Orthofix was founded in 1980. It employs 1,001 to 5,000 people.

Where is Orthofix based?

Orthofix is headquartered in Lewisville, United States, in the North America region.

How does Orthofix make money?

Five revenue lines are on record. Spine Solutions are the primary driver. The others are limb Reconstruction, bone Growth Therapies (Therapeutic Solutions), biologics and surgical Navigation.

Who are Orthofix's main competitors?

Direct peers on record are Globus Medical, Alphatec Holdings and Integra LifeSciences. Broad incumbents are Stryker Corporation, Medtronic, Zimmer Biomet, Johnson & Johnson (DePuy Synthes) and Smith+Nephew. Emerging players are SI-BONE and Treace Medical Concepts.

Does Orthofix have an API?

No public API is recorded for Orthofix.

What industry is Orthofix in?

Orthofix's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAKALAE, Spine (Orthopedic Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsBank of America Corp DE Makes New Investment in Orthofix Medical Inc. $OFIXBank of America Corp DE acquired a new stake in Orthofix Medical, buying 291,827 shares worth about $2.67 million in Q2. The company reported a loss of $0.39 per share for the quarter, beating estimates, and analysts have an average "Hold" rating with a $14.75 price target.Investing.comStock Market News - Investing.com IndiaOrthofix Medical reported Q2 2026 adjusted loss of $0.39 per share, beating the $0.40 estimate, with revenue of $210.93 million, above the $209.28 million forecast. The company raised its full-year sales and EBITDA guidance and secured a European distributor. Juniper Investment Company sold 310,000 shares of Orthofix in September 2026.Investing.comInsider Trading News Today - Investing.comJuniper Investment Company sold 310,000 Orthofix Medical shares in September 2026, totaling about $2.73 million. The company's Q2 2026 results beat expectations with revenue of $210.93 million and an adjusted loss of $0.39 per share. Orthofix raised its full-year guidance and secured a European distributor.Ticker ReportComparing Orthofix Medical (NASDAQ:OFIX) & LENSAR (NASDAQ:LNSR)A comparison of LENSAR and Orthofix Medical finds LENSAR more favorable, with a consensus target price of $11.50 versus $14.75. LENSAR beats Orthofix on 8 of 14 factors, including higher net margin and lower P/E ratio, though Orthofix has higher revenue and institutional ownership.Investing.comInsider Trading News Today - Investing.comJuniper Investment Company acquired 310,000 shares of Orthofix Medical in mid-September, spending about $2.73 million. The stock rose 8.4% to $9.44, and the company reported Q2 adjusted loss of $0.39, beating forecasts. Stifel keeps a Buy rating with a $13.00 price target.Markets DailyLENSAR (NASDAQ:LNSR) versus Orthofix Medical (NASDAQ:OFIX) Head-To-Head ReviewOrthofix Medical and LENSAR are compared on institutional ownership, profitability, and analyst ratings. Orthofix has 89.8% institutional ownership and a consensus price target of $14.75, while LENSAR has 40.1% institutional ownership and a target of $11.50. Analysts favor Orthofix due to its stronger consensus rating and higher upside.Ticker ReportBrokerages Set Orthofix Medical Inc. (NASDAQ:OFIX) PT at $14.75Orthofix Medical shares have an average analyst rating of "Hold" with a $14.75 price target. The company reported Q2 EPS of -$0.39, beating estimates, and revenue of $210.93 million. Institutional investors hold 89.76% of the stock.Ticker ReportMoore Capital Management LP Purchases New Shares in Orthofix Medical Inc. $OFIXMoore Capital Management LP acquired a new stake in Orthofix Medical, purchasing 85,421 shares valued at about $781,000 in Q2. Analysts have a consensus "Hold" rating with a price target of $14.75, and the company reported Q2 EPS of -$0.39, beating estimates.Ticker ReportSenseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Orthofix Medical (NASDAQ:OFIX) Critical ReviewA MarketBeat comparison reviewed small-cap healthcare stocks Orthofix Medical and Senseonics Holdings across dividends, institutional ownership, profitability, analyst ratings, earnings and valuation. Orthofix reported $822.31 million in revenue versus Senseonics' $35.26 million, with Senseonics' higher earnings per share and lower P/E ratio. Senseonics beat Orthofix on 8 of 14 factors, with a consensus price target of $17.20 versus $14.75.Markets DailyBrokerages Set Orthofix Medical Inc. (NASDAQ:OFIX) PT at $14.75Orthofix Medical received a consensus "Hold" rating from five analysts, with one sell, one hold and three buy ratings, and an average 12-month target of $14.75. Wall Street Zen downgraded the stock to "hold," while Barrington raised its target to $17.00 and Canaccord Genuity cut its to $13.00. The company reported quarterly EPS of -$0.39 on $210.93 million revenue.